Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels and reduced glucagon levels in type 2 diabetes. - Ahrén,B.; Landin-Olsson,M.; Jansson,PA.; Svensson,M.; Holmes,D.; Schweizer,A. (J Clin Endocrinol Metab, 2004)